NGNE Earnings

Quarterly EPS
$-1.19
Q3 2024
$-1.00
Q4 2024
$-1.08
Q1 2025
$-1.05
Q2 2025
$-0.99
Q3 2025
$-1.12
Q4 2025
$-1.39
Q1 2026
$-1.53
Q2 2026
Latest RevenueN/A
Latest Net Income-34488000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.530-34488000-45.7%
Q1 2026-$1.390-30934000-28.7%
Q4 2025-$1.120-24735000-12.0%
Q3 2025-$0.990-20953000+16.8%
Q2 2025-$1.050-22016000-100.0%+3.7%
Q1 2025-$1.080-22647000-8.0%
Q4 2024-$1.000-19514000-198.0%
Q3 2024-$1.190-20217000
Q2 2024-$1.09925.0K-18492000
Q1 2024-$1.000-16921000
Q4 2023$1.0202.4M
Neurogene (NGNE) — Earnings